Researchers at UTHealth Houston have initiated a new stem cell therapy trial aimed at reducing neuroinflammation to prevent Alzheimer’s disease before symptoms emerge, an approach that could revolutionise treatment strategies, offering new hope for at-risk individuals.
Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions worldwide. Characterised by the build-up of beta-amyloid plaques and tau protein tangles in the brain, the disease leads to cognitive decline, memory loss and eventually dementia. Now, a new stem cell therapy trial at UTHealth Houston is exploring ways to prevent and reduce neuroinflammation, potentially stopping Alzheimer’s disease before symptoms even appear.
Preclinical studies in animal models of Parkinson’s and Alzheimer’s disease…